Hims & Hers Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Hims & Hers Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Hims & Hers Health, Inc. HIMS.N reported a quarterly adjusted loss of 37 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 17 cents. The mean expectation of fourteen analysts for the quarter was for a loss of one cent per share. Wall Street expected results to range from -15 cents to 9 cents per share.
Revenue rose 38.2% to $753.21 million from a year ago; analysts expected $699.89 million.
Hims & Hers Health, Inc.'s reported EPS for the quarter was a loss of 37 cents.
The company reported a quarterly loss of $86.29 million.
Hims & Hers Health, Inc. shares had fallen by 8.9% this quarter and lost 2.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 114% in the last three months.
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 12 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Hims & Hers Health, Inc. is $28.50, about 11.5% below its last closing price of $31.77
This summary was machine generated from LSEG data August 10 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.01 | -0.37 | Missed |
Mar. 31 2026 | 0.04 | -0.19 | Missed |
Dec. 31 2025 | 0.05 | 0.08 | Beat |
Sep. 30 2025 | 0.10 | 0.06 | Missed |
Recent news on Hims & Hers Health
See all newsBrief: Hims & Hers Health Expands Testosterone Care With Injectable And Oral TRT
Hims & Hers Health launches online weight management service for men in Germany
Corrected: US FDA takes step to change peptide compounding policy (Oct 15)
Brief: Hims & Hers Names Jon Franklin As Chief Accounting Officer
Brief: Hims & Hers Names Chief Medical Officers In The Uk And Australia, Deepening Its Investment In Local Clinical Leadership